These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 17479195
21. Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity. Yang TL, Chen MF, Luo BL, Xie QY, Jiang JL, Li YJ. Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):401-7. PubMed ID: 15915325 [Abstract] [Full Text] [Related]
27. Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells. Lu CW, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y. Atherosclerosis; 2010 Mar; 209(1):66-73. PubMed ID: 19775692 [Abstract] [Full Text] [Related]
28. Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH. Eid HM, Lyberg T, Arnesen H, Seljeflot I. Atherosclerosis; 2007 Oct; 194(2):e1-8. PubMed ID: 17141242 [Abstract] [Full Text] [Related]
29. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, Imaizumi T. Circ Res; 2003 Feb 07; 92(2):226-33. PubMed ID: 12574151 [Abstract] [Full Text] [Related]
30. Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction. Ando R, Ueda S, Yamagishi S, Miyazaki H, Kaida Y, Kaifu K, Yokoro M, Nakayama Y, Obara N, Fukami K, Takeuchi M, Okuda S. Diab Vasc Dis Res; 2013 Sep 07; 10(5):436-41. PubMed ID: 23766377 [Abstract] [Full Text] [Related]
31. [Alterations in reactive oxygen species and dimethylarginine dimethylaminohydrolase-asymmetric dimethyl-arginine system in the process of endothelial cell senescence induced by high glucose]. Yi TN, Zhang J, Yu SJ, Gao TS. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 May 07; 23(5):275-8. PubMed ID: 21549064 [Abstract] [Full Text] [Related]
32. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion. Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T. Exp Gerontol; 2014 Feb 07; 50():45-51. PubMed ID: 24269305 [Abstract] [Full Text] [Related]
33. Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene. Zhang JG, Liu JX, Li ZH, Wang LZ, Jiang YD, Wang SR. Chin Med J (Engl); 2007 Dec 05; 120(23):2132-7. PubMed ID: 18167189 [Abstract] [Full Text] [Related]
35. The mechanism of long-term low-dose asymmetric dimethylarginine inducing transforming growth factor-β expression in endothelial cells. Feng Y, Zhang D, Zhang Y, Zhang Q, Liu W. Int J Mol Med; 2013 Jan 05; 31(1):67-74. PubMed ID: 23175152 [Abstract] [Full Text] [Related]
36. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production. Pope AJ, Karrupiah K, Kearns PN, Xia Y, Cardounel AJ. J Biol Chem; 2009 Dec 18; 284(51):35338-47. PubMed ID: 19820234 [Abstract] [Full Text] [Related]
37. Asymmetric dimethylarginine regulates the lipopolysaccharide-induced nitric oxide production in macrophages by suppressing the activation of NF-kappaB and iNOS expression. Pekarova M, Kubala L, Martiskova H, Bino L, Twarogova M, Klinke A, Rudolph TK, Kuchtova Z, Kolarova H, Ambrozova G, Kuchta R, Kadlec J, Lojek A. Eur J Pharmacol; 2013 Aug 05; 713(1-3):68-77. PubMed ID: 23665490 [Abstract] [Full Text] [Related]
40. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension. Li XH, Peng J, Tan N, Wu WH, Li TT, Shi RZ, Li YJ. Vascul Pharmacol; 2010 Aug 05; 53(5-6):223-9. PubMed ID: 20840872 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]